Malaria today -- The cost and cost-effectiveness of antimalarial drugs -- The case for a global subsidy of antimalarial drugs -- An international system for procuring antimalarial drugs -- A brief history of malaria -- The parasite, the mosquito, and the disease -- The human and economic burden of malaria -- Malaria control -- Antimalarial drugs and drug resistance -- Research and development for new antimalarial drugs -- Maximizing the effective use of antimalarial drugs.
0
OTHER EDITION IN ANOTHER MEDIUM
Title
Saving lives, buying time.
TOPICAL NAME USED AS SUBJECT
Antimalarials-- Economic aspects.
Drug resistance in microorganisms.
Pharmaceutical policy.
Antimalarials-- economics.
Antimalarials-- therapeutic use.
Drug Costs.
Drug Resistance.
Malaria-- drug therapy.
Antimalariamittel
Chemotherapie
Drug resistance in microorganisms.
HEALTH & FITNESS-- Diseases-- Contagious.
Kosten
Malaria
MEDICAL-- Infectious Diseases.
Pharmaceutical policy.
(SUBJECT CATEGORY (Provisional
HEA-- 039040
MED-- 022090
DEWEY DECIMAL CLASSIFICATION
Number
616
.
9/362061
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RC159
.
A5
Book number
S28
2004b
OTHER CLASS NUMBERS
Class number
QX
700
Class number
2004
M-473
Class number
WC
770
Book Number
S267
2004
System Code
rvk
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Arrow, Kenneth J., (Kenneth Joseph),1921-2017.
Gelband, Hellen.
Panosian, Claire.
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
Institute of Medicine (U.S.)., Committee on the Economics of Antimalarial Drugs.